Anxiety and depressive disorders in patients with diabetes mellitus type 2 and cerebrovascular disease
Abstract
Aims.
Current study was aimed to identify symptoms and risk factors for depression and anxiety and to estimate quality of life (QoL) in patients with diabetes mellitus type 2 (T2DM) and cerebrovascular disease (CVD).
Materials and methods.
We examined 73 patients with T2DM. 1st group included 49 patients with T2DM and CVD, 2nd group - 24 patients with T2DM and no cardiovascular pathology. The groups were not significantly different in terms of age, BMI, level of HbAlc, fasting and postprandial glycemia. All patients received antihyperglycemic and antihypertensive therapy. Anxiety and depression were diagnosed with Beck Depression Inventory and Spielberger State and Trait Anxiety Scale (SSTAS). SF-36 questionnaire was used for estimation of QoL.
Results.
2nd group showed symptoms of anxiety and depressive disorders in 100% and 75% of cases, respectively. 1st group showed significantly more prominent anxiety and depression symptoms. Risk factors for anxiety and depressive disorders in patients with T2DM and CVD were found to be senior age, obesity and atherogenic dyslipidemia.
Conclusion.
Cardiovascular comorbidity in T2DM significantly decreases QoL, especially in aspects of physical functioning and vitality. Timely diagnostics of anxiety and depression in patients with T2DM and CVD requires development of screening and rehabilitation programs.
Current study was aimed to identify symptoms and risk factors for depression and anxiety and to estimate quality of life (QoL) in patients with diabetes mellitus type 2 (T2DM) and cerebrovascular disease (CVD).
Materials and methods.
We examined 73 patients with T2DM. 1st group included 49 patients with T2DM and CVD, 2nd group - 24 patients with T2DM and no cardiovascular pathology. The groups were not significantly different in terms of age, BMI, level of HbAlc, fasting and postprandial glycemia. All patients received antihyperglycemic and antihypertensive therapy. Anxiety and depression were diagnosed with Beck Depression Inventory and Spielberger State and Trait Anxiety Scale (SSTAS). SF-36 questionnaire was used for estimation of QoL.
Results.
2nd group showed symptoms of anxiety and depressive disorders in 100% and 75% of cases, respectively. 1st group showed significantly more prominent anxiety and depression symptoms. Risk factors for anxiety and depressive disorders in patients with T2DM and CVD were found to be senior age, obesity and atherogenic dyslipidemia.
Conclusion.
Cardiovascular comorbidity in T2DM significantly decreases QoL, especially in aspects of physical functioning and vitality. Timely diagnostics of anxiety and depression in patients with T2DM and CVD requires development of screening and rehabilitation programs.
About the Authors
Inessa Ivanovna Dubinina
Ryazan State Medical University
Russian Federation
Russian Federation
Vladimir Alexeevich Zhadnov
Ryazan State Medical University
Russian Federation
Russian Federation
Svetlana Vital'evna Yankina
Ryazan State Medical University
Russian Federation
Russian Federation
Alexandra Viktorovna Solov'eva
Ryazan State Medical University
Russian Federation
Russian Federation
References
1. Dedov II, Shestakova MV, Ametov AS, Antsiferov MB, Galstyan GR, Mayorov AYu, Mkrtunyan AM, Petunina NA, Sukhareva OYu. Consensus statement by a panel of experts of the Russian Association of Endocrinologists (RAE) on initiation and intensification of hypoglycemic therapy for type 2 diabetes mellitus. Diabetes mellitus. 2011;(1):95-105.
2. Dedov II. Diabetes mellitus: development of technologies in diagnostics, treatment and prevention. Diabetes mellitus. 2010;(3):6-13.
3. Suntsov YuI, Bolotskaya LL, Maslova OV, Kazakov IV. Epidemiology of diabetes mellitus and prognosis of its prevalence in the Russian Federation. Diabetes mellitus. 2011;(1):15-18.
4. Gusev EI, Skvortsova VI, Stakhovskaya LV. Epidemiologiya insul'ta v Rossii. Neuroscience and behavioral physiology. 2003; (8 Suppl. Stroke):4-9.
5. Messier C, Awad N, Gagnon M. The relationships between atherosclerosis, heart diseas, type 2 diabetes and dementia. Neurol Res. 2004 Jul;26(5):567-572.
6. Ckvortsova VI. Snizhenie zabolevaemosti, smertnosti i invalidnosti ot insul'tov v Rossiyskoy Federatsii. II Rossiyskiy mezhdunarodnyy kongress: Tserebrovaskulyarnaya patologiya i insul't. Neuroscience and behavioral physiology. 2007; (8 Suppl. Stroke):25-27.
7. Desjarlais R, Eisenberg L, Good B, Kleinman A. World mental health. Problems and priorities in lowincome countries. New York: Oxford University Press; 1995.
8. Krasnov VN. Sovremennye podkhody k terapii depressiy. Russian medical journal. 2002;(12-13):553- 560.
9. Kobylina OV, Gekht AB, Favorova OO, Nikolaeva TYa, Gusev EI. Genetic aspects of ischemic stroke. Neuroscience and behavioral physiology. 2008;108(23 suppl. Stroke):49-57.
10. Antsiferov MB, Mel'nikova OG, Drobizhev MYu, Zakharchuk TA. Sakharnyy diabet i depressivnye rasstroystva. Russian medical journal. 2003;11(27):1480-1483.
11. Гусев ЕИ, Боголепова АН. Depressive disorders in patients after stroke. Neuroscience and behavioral physiology. 2008;108(22 suppl. stroke):10-15.
12. Kanner AM, Barry JJ. The impact of mood disorders in neurological diseases: should neurologists be concerned? Epilepsy Behav. 2003 Oct;4 Suppl 3:S3-13.
13. Shishkova JA, Surkova EV, Motovilin OG, Mayorov AYu. Quality of life diabetes mellitus: definitions, modern research approaches, tool for evaluation. Diabetes mellitus. 2011;(3):70-75.
Review
For citations:
Dubinina I.I., Zhadnov V.A., Yankina S.V., Solov'eva A.V. Anxiety and depressive disorders in patients with diabetes mellitus type 2 and cerebrovascular disease. Diabetes mellitus. 2012;15(4):59-62. (In Russ.)
Views:
4349
Email this article 
